Three-day canoe trip on the Colorado River for Cancer Survivors

WHAT: Three-day canoe trip and camping on the Colorado River

WHO: Single cancer survivors who are 21 and older and at least three months post-treatment

WHY: Fun, connection, outdoor adventure, and informal discussion about life and love for the single cancer survivor

WHEN:
Thursday, August 26: Trip participants arrive in Denver, CO (mid-day) or Grand Junction, CO (evening). We will camp together Thursday night in Fruita or you may make arrangements for a hotel in Grand Junction if you prefer.
Friday, August 27: Meet at the Colorado River put-in site early in the morning. Spend the day paddling to the campsite on the scenic Colorado River.
Saturday, August 28: Hike, play in the water, or spend time playing games or talking by the campfire. Two awesome massage therapists are also coming on the trip to offer body work.
Sunday, August 29: Paddle to the take-out point of the river, and arrive in Grand Junction by mid-afternoon for departure and flights home.

REGISTER TODAY - ONLY 20 SPOTS: https://www.eventbrite.com/register?orderid=13339581046&eid=400289276

Experienced commercial guides from Centennial Canoe Outfitters will lead the trip as well as prepare delicious meals for trip participants. Check out the Centennial Canoe Outfitters website for photos, video and more information about the stretch of the river we'll be paddling: http://www.centennialcanoe.com/index.php/trips/trip/colorado_river_co/

This trip is sponsored by Centennial Canoe Outfitters and Tamika & Friends.

For more on Centennial canoe trips watch this slideshow:
http://www.facebook.com/video/video.php?v=1450074926329

THE FINE PRINT: A $50 deposit is due by August 16th to hold your spot. The deposit is the only cost for the trip itself, and will be used to tip the guides (who are not getting paid) at the end of the trip.

Travel costs are the responsibility of the participant. A limited number of travel scholarships may be available. If interested, please email asinglecell@gmail.com and let us know why you need travel assistance no later than July 20. Recipients will be notified by August 2.

REGISTER TODAY - ONLY 20 SPOTS: https://www.eventbrite.com/register?orderid=13339581046&eid=400289276

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap